MyEG

My E.G. Services Berhad (MyEG) is a premier digital services provider in Malaysia that has significantly expanded into the healthcare and life sciences sectors. The company operates a comprehensive digital health ecosystem, offering services such as COVID-19 screening, health management platforms, and digital health passports. MyEG gained prominence in the life sciences space through its strategic partnership with Anhui Zhifei Longcom Biopharmaceutical to conduct Phase 3 clinical trials and manage the distribution of the Zifivax COVID-19 vaccine in Malaysia. Beyond pandemic response, the company provides a range of technology-driven health solutions, including online doctor consultations and medical insurance integration. MyEG leverages its extensive technological infrastructure, including blockchain and artificial intelligence, to streamline public health administration and improve medical accessibility across Southeast Asia. The company is publicly traded on Bursa Malaysia and continues to diversify its healthcare portfolio through strategic investments and regional partnerships.